Wall Street dives into Regeneron’s robust prospects By Investing.com Stocks March 31, 2024 Regeneron (NASDAQ:) Pharmaceuticals, Inc. continues to be a leading force in the biopharmaceutical industry, with strategic movements into new therapeutic…